The Valley Desk

NCT00328172 · Interventional trial

Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients

Overall registry status Completed

Phase 2

Conditions Diabetes Mellitus, Type 2

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov